Corey Davis, J.D., M.S.P.H., is deputy director of the Network’s Southeastern Region Office and  Director of the Harm Reduction Legal Project. Corey was previously a Senior Attorney at the National Health Law Program (NHeLP), where he helped to advance access to quality health care for low-income and underserved individuals. Before joining NHeLP Corey served as Employment Rights Attorney at Equality Advocates Pennsylvania, where he represented lesbian, gay, bisexual and transgender (LGBT) individuals before administrative commissions and in state and federal courts. He previously oversaw a street-based legal clinic sited at Philadelphia’s syringe exchange program.

Corey has served as chair of a county board of health, chair of the board of the North Carolina Harm Reduction Coalition, and vice-chair of the North Carolina Harm Public Health Foundation, among other positions. He is a recipient of the International AIDS Society’s Young Investigator Award andhas published extensively in the lay and academic press. Corey received his B.S. from the Indiana University of Pennsylvania, his M.S.P.H. from the University of North Carolina at Chapel Hill and his J.D. from Temple University. Corey is barred in Pennsylvania and New Jersey as well as various federal courts.

View a collection of research, resources and trainings produced by Corey below.

Articles & Resources

Ensuring Access to Clean Needles Can Save Lives, but Legal Barriers Persist

Law & Policy InsightsHarm Reduction Legal ProjectHarm Reduction Legal Project ResourcesOpioid Misuse and Overdose PreventionSubstance Use Prevention and Harm Reduction

February 5, 2021
by Amy Lieberman and Corey Davis

The United States continues to experience an unprecedented level of drug-related harm. While the failure to prevent this harm is most notable in the number of overdose deaths, which are now at their highest level on record, it is evident in other areas as well. Of particular importance from a policy perspective, bloodborne disease infections related to syringe sharing are also on the rise, with recent outbreaks in Kentucky, Massachusetts, and Indiana, among other states. Cases of infective endocarditis, which is caused largely by unsafe injection, are increasing as well.

Read more

Determining Whether Federal Law Prohibits the Mailing of Naloxone

Law & Policy InsightsHarm Reduction Legal ProjectHarm Reduction Legal Project ResourcesOpioid Misuse and Overdose PreventionSubstance Use Prevention and Harm Reduction

December 3, 2020
by Corey Davis

The Network’s Harm Reduction Legal Project works to address the legal and policy barriers that impede the establishment and expansion of evidence-based harm reduction measures such as naloxone distribution, syringe access programs, and access to evidence-based substance use disorder treatment. One of the questions frequently received by the Project is whether federal law prohibits harm reduction organizations and similar groups who are authorized to distribute naloxone from mailing the medication.

Read more

Naloxone Prescription Mandates

Fact SheetHarm Reduction Legal ProjectHarm Reduction Legal Project ResourcesOpioid Misuse and Overdose PreventionSubstance Use Prevention and Harm Reduction

October 22, 2020
by Amy Lieberman and Corey Davis

Drug overdose continues to claim the lives of tens of thousands of people in the U.S. every year. Opioids, both prescription painkillers and street drugs such as heroin and illicitly manufactured fentanyl, are responsible for the majority of these deaths. In response, states have passed legislation to increase access to the opioid overdose reversal medication naloxone, including provisions that allow for the distribution of naloxone through pharmacies. Some states have gone further and now require that naloxone be prescribed or offered to some patients. This fact sheet describes those requirements and links to the relevant laws.

View page

Q&A: Access to Care for Individuals with Opioid Use Disorder

Law & Policy InsightsCOVID-19Harm Reduction Legal ProjectHarm Reduction Legal Project ResourcesSubstance Use Prevention and Harm Reduction

October 6, 2020
by Amy Lieberman and Corey Davis

In this Q&A, Corey Davis, deputy director of the Network’s Southeastern Region Office and director of the Network’s Harm Reduction Legal Project; and Amy Lieberman, senior attorney, for the Network’s Harm Reduction Legal Project, discuss some of the key elements in the chapter they authored, Access to Care for Individuals with Opioid Use Disorder, for the Report.

Read more

Characteristics of Statewide Naloxone Distribution Mechanisms

50-state surveyOpioid Misuse and Overdose PreventionHarm Reduction Legal ProjectHarm Reduction Legal Project ResourcesSubstance Use Prevention and Harm Reduction

August 7, 2020
by Corey Davis

This fact sheet provides information on Pennsylvania's Act 139, which provides limited immunity to overdose victims and bystanders that seek medical help, and increases accesss to naloxone, a drug that can reverse the effects of an opioid overdose.

View page

Legality of Dispensing and Administering Expired Naloxone in Georgia

Fact SheetSubstance Use Prevention and Harm ReductionHarm Reduction Legal Project ResourcesHarm Reduction Legal ProjectOpioid Misuse and Overdose Prevention

June 4, 2020
by Amy Lieberman and Corey Davis

While states have passed various laws designed to increase access to naloxone, a life-saving opioid overdose reversal medication, none explicitly address the legality of dispensing naloxone that is past its expiration date. This fact sheet discusses whether Georgia laws forbid the prescription, dispensing, distribution, possession, or administration of expired naloxone and whether such actions impact the risk of civil liability for medical professionals who prescribe or dispense naloxone or laypeople who distribute or administer it.

View page

Legality of Dispensing and Administering Expired Naloxone in the District of Columbia

Fact SheetSubstance Use Prevention and Harm ReductionHarm Reduction Legal Project ResourcesHarm Reduction Legal ProjectOpioid Misuse and Overdose Prevention

May 21, 2020
by Amy Lieberman and Corey Davis

This fact sheet discusses whether District of Columbia laws forbid the prescription, dispensing, distribution, possession, or administration of expired naloxone and whether such actions impact the risk of civil liability for medical professionals who prescribe or dispense naloxone or laypeople who distribute or administer it.

View page